Citadel Advisors LLC 13D and 13G filings for Satsuma Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
Citadel Advisors LLC | 364,785 2.100% |
-652,697 (-64.15%) |
Filing |